SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada ========================================================================================= * David M. Goldfarb * Louise C. Mâsse * Allison W. Watts * Sarah M. Hutchison * Lauren Muttucomaroe * Else S. Bosman * Vilte E. Barakauskas * Alexandra Choi * Michael A. Irvine * Frederic Reicherz * Daniel Coombs * Collette O’Reilly * Sadaf Sediqi * Hamid R. Razzaghian * Manish Sadarangani * Sheila F. O’Brien * Pascal M. Lavoie ## Abstract **Importance** Contact-tracing studies suggest minimal secondary transmission in schools. However, there are limited school data accounting for asymptomatic cases, particularly late in the 2020/21 school year, and in the context of uninterrupted in-person schooling and widespread community transmission. **Objectives** To determine the SARS-CoV-2 seroprevalence in a sample of school staff, compared to the community, and to COVID-19 rates among all students and staff within the same school population. **Design** Incident COVID-19 cases among students and school staff using public health data, with an embedded cross-sectional serosurvey among school staff sampled from February 10 to May 15, 2021, comparing to age, sex and geographic location-matched blood donors sampled in January 2021. **Setting** Vancouver School District (British Columbia, Canada) from kindergarten to grade 12. **Participants** Active **s**chool staff enrolled from February 3 to April 23, 2021. **Main outcome measures** SARS-CoV-2 antibodies in a sample of school staff using spike (S)-based testing (unvaccinated staff) or N-based serology testing (vaccinated staff). **Results** The incidence of COVID-19 cases among students attending in-person was 9.8 per 1,000 students during the 2020/21 school year (N = 47,280 students), and among staff was 13 per 1,000 since the beginning of the pandemic (N = 7,071 active school staff). In total, 1,689 school staff (64% elementary, 28% secondary, 8.3% school board staff or multiple grades) completed the questionnaire, 78.2% had classroom responsibilities, and spent a median of 17.6 hours in class per week [IQR: 5.0 – 25 hours]. Although 21.5% (363/1,686) reported close contact with a COVID-19 case, only 1.4% (24/1688) of the school staff reported having had a positive viral nucleic acid test. Of this group, five believed they acquired the infection at school. The adjusted seroprevalence in staff who gave blood (1,556/1,689, 92.1%) was 2.3% [95%CI: 1.6 – 3.2%] compared to 2.3% [95%CI: 1.7 – 3.0%] in blood donors. **Conclusion and relevance** Despite high reported COVID-19 cases among students and staff, and frequent within-school exposures, we found no detectable increase in seroprevalence among school staff above the community seroprevalence. These findings corroborate claims that, with appropriate mitigation strategies, in-person schooling is not associated with significantly increased risk for school staff. **Question** What was the prevalence of COVID-19 infections in school staff who maintained in-person schooling during the 2020/21 school year in Vancouver, British Columbia, and how does it compare to the risk of COVID-19 infection in the community. **Findings** As of March 4, 2021, the incidence of COVID-19 cases among school staff was 13 per 1,000 (N = 7,071 school staff) since the beginning of the pandemic. In a cross-sectional seroprevalence analysis from February 10 to May 15, 2021, the adjusted seroprevalence among a sample of school staff (N = 1,556) was 2.3% [95%CI: 1.6 – 3.2%], compared to 2.3% [95%CI: 1.7 – 3.0%] in 1:2 age, sex and geographical location (by postal code)-matched reference group of blood donors. **Meaning** We found no detectable increase in seroprevalence among school staff above the community seroprevalence. These findings corroborate claims that, with appropriate mitigation strategies in place, in-person schooling is not associated with significantly higher risk for school staff. Keywords * SARS-CoV-2 * COVID-19 seroprevalence * schools * occupational risk ## Introduction SARS-CoV-2 forced over a billion students out-of-school globally in the Spring 2020. Decisions to close schools, motivated by high case mortality in populations, had serious implications for children’s emotional, social, physical and educational outcomes1. The risk of secondary SARS-CoV-2 transmission within schools has been heavily debated. On one hand, viral culture studies suggest that children may be less infectious than adults2, contact tracing studies show low rates of in-school transmission3-13, and surveillance studies demonstrate little increased transmission when schools re-opened14-19. On the other hand, seroprevalence studies have been conducted to account for asymptomatic transmission, but many studies have reported data early in the pandemic, or in the setting of partial school closure15,20-22. In the spring of 2020, Public Health authorities in British Columbia (BC) ordered a cessation of in-person schooling provincially, with a transition to remote learning from home. Like most of the world, the province went under a nearly complete lockdown between March and early June when most sectors of the economy were paused. While BC reported relatively low community viral transmission early in the first pandemic wave, roughly >50 times more COVID-19 cases were reported (121,762 cases reported in a population of 5,017,000) between July 1, 2020 and April 23, 2021, compared to February to May 2020. Despite increasing cases in late summer, BC was unique within Canada in that it maintained in-person schooling for the entire duration of the 2020/2021 school year starting September 8, 2020, except for winter (December 18, 2020 to January 4, 2021) and spring (March 12 to March 29, 2021) breaks. The main goal of this study was to determine the SARS-CoV-2 seroprevalence in school staff in Vancouver public schools during the 2020/21 school year. The secondary objectives were to compare the seroprevalence in school staff to a reference population of matched Canadian blood donors, and to report on the incidence of COVID-19 cases among all students and school staff. We hypothesized that with mitigation measures the occupational risk of SARS-CoV-2 infection among school staff would remain low and comparable to the community risk. ## Methods ### Study design The baseline questionnaire and serology data collected among active school staff of the Vancouver School District (the District) who are being followed for one year, was used to determine SARS-CoV-2 seroprevalence. Seroprevalence in school staff was compared to an age, sex and geographic location-matched sampled of blood donors collected in January 2021. In addition, we obtained retrospective data on COVID-19 cases in all staff and students attending the District from Vancouver Coastal Health (VCH, detailed below). ### Participants *School staff* self-enrolled from February 3 to April 23, 2021 after receiving an introduction email from school principals from the District in early February 2021, inviting them to register online at: [https://www.bcchr.ca/COVIDatschools](https://www.bcchr.ca/COVIDatschools), for both a questionnaire and to provide blood for serology testing. A flyer was posted on the District website, and reminder emails were also sent. Interested participants completed a screener to identify whether they met eligibility criteria. Staff were included if they were a current, full or part-time staff member (confirmed by District email address). Staff who reported being temporary staff, on-leave, or on-call with no reported classroom time were excluded. Informed consent was obtained from all school staff. The study was approved by the University of British Columbia Children’s and Women’s Research Ethics Board (H20-03593). *Blood donors* were screened prior to donation to ensure they were in good health, including questions about COVID-19. People were ineligible to donate blood if they had a recent COVID-19 infection two weeks after symptoms resolved, or were hospitalized within 3 weeks before. ### Study setting The District is a large, urban school district with 89 elementary schools and 18 secondary schools (47,280 students and 7,071 school staff) located in the city of Vancouver (BC, Canada ∽600,000 population in the city of Vancouver with 2.6 million population in the urban area). Following a complete closure in March 2020, schools opened in a limited fashion, except for students who use English as a second language and those with complex learning needs who were able to attend in-person 5 days/week until June 30, 2020. On September 8, 2020 schools reopened for the 2020/21 school year, except for a winter break from December 18, 2020 to January 4, 2021, and spring break from March 12 to 29, 2021. COVID-19 mitigations measures implemented in District schools as well as indications for viral testing are detailed in **Appendix 1**. ### Data Collection Data was collected from school staff using a questionnaire that asked, among others, about risk factors for COVID-19, household structure, physical distancing behavior, close contacts with COVID-19 cases (defined by asking: *“someone diagnosed with COVID-19 with whom you’d been within two meters of for greater than two minutes”*), history of viral testing (including dates and symptoms) and vaccination, etc.23 A second questionnaire about mental health and vaccine perception was also administered but not reported in this paper. COVID-19 vaccination in blood donors was collected by asking at the time of blood donation. To estimate the degree of exposure to known COVID-19 cases, we obtained data from VCH’s Case and Contact Management Interface. The District provided student and staff lists to VCH, which linked the data to determine the incidence of SARS-CoV-2 infection among students and staff in District schools. Adult education staff were excluded. Staff and students affiliated with Vancouver Alternate Secondary School programs were counted as attending a single school for the purposes of incidence calculations. Given that the history of viral testing in the prospective school staff sample was obtained via questionnaires, we selected the median date of questionnaire completion (March 4, 2021) as the end date for data extraction. We extracted all lab-confirmed, probable, and epidemiologically-linked COVID-19 cases reported to VCH. To assess the incidence of known infection among staff over the course of the pandemic, we calculated the incidence of reported staff cases from January 15, 2020 (corresponding to the first case reported to VCH) to March 4, 2021. Similarly, exposure to student cases during the school year was estimated by calculating the incidence from September 8, 2020 to March 4, 2021. ### Serology testing Blood samples were collected from February 10 to May 15 2021, at clinics set-up in various participating Vancouver schools, at the BC Children’s Hospital or outpatient clinical laboratories in metro Vancouver. The presence of antibodies against SARS-CoV-2 was used as a marker of prior COVID-19 infection, using dual S- and N-based serology testing, where S-based serology was used in unvaccinated participants and N-based serology testing was used with vaccinated participants (**Supplemental Figure 1**). ![Supplemental Figure 1:](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2021/06/18/2021.06.16.21258861/F1.medium.gif) [Supplemental Figure 1:](http://medrxiv.org/content/early/2021/06/18/2021.06.16.21258861/F1) Supplemental Figure 1: Seroprevalence case assignment strategy To distinguish between antibodies due to COVID-19 versus antibody responses to vaccination, a dual, stepwise serology testing strategy was employed, where more sensitive S-based testing (using ORTHO assay) was used in unvaccinated school staff who composed the majority of our study sample, and virus-specific N-based antibody testing (using Roche assay) was used in vaccinated school staff. *One case reported PCR positive testing had subthreshold S-based serology reactivity of 0.39. ![Supplemental Figure 2:](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2021/06/18/2021.06.16.21258861/F2.medium.gif) [Supplemental Figure 2:](http://medrxiv.org/content/early/2021/06/18/2021.06.16.21258861/F2) Supplemental Figure 2: Incidence of reported COVID-19 cases (Vancouver Coastal Health) per students (n = 47,280) and staff (n = 7,071) between schools of the Vancouver School District (21 of 107 schools had zero COVID-19 cases among students and staff, and are not included in this graph). Antibodies directed against the spike (S1) protein were detected using the Ortho T *VITROS™* Anti-SARS-CoV-2 *Total antibody assay* (Ortho IgG; Ortho Clinical Diagnostics, Rochester, NY), a Health Canada and FDA-licensed qualitative assay which detects all types of antibodies (IgA, IgG and IgM). S-based serology testing was done on a Vitros 5600 analyser at the BC Children’s & Women’s Hospital Laboratory, which is accredited for clinical testing. Literature and in-house validation demonstrated this assay can identify both symptomatic and asymptomatic infected individuals >7 days post illness onset with a sensitivity between 90.7% and 97.7%, and specificities between 99.4% and 100% 24,25. Specimens were considered reactive at a cut-off index ≥1.00. All S-tested negative samples with S-antibody indexes >99th centile were also confirmed to be negative on the Roche assay. Testing for anti-nucleocapsid (N) protein SARS-CoV-2 antibodies was performed using the Roche Elecsys*™* Anti-SARS-CoV-2 (Roche T; Roche, USA). This qualitative total antibody assay is Health Canada and FDA-licensed with reported sensitivity of 88.5% – 100% at least 14 days post-COVID-19 onset and specificity of 99.8% –100% 26-28. Testing was performed on a Cobas e601 analyzer at St. Paul’s Hospital Laboratory. Blood donors were tested for both SARS-CoV-2 spike and N antibodies using the Roche Elecsys™ Anti-SARS-CoV-2 S and Anti-SARS-CoV-2 (Roche, USA) assays, respectively, on a Cobas e801 analyzer, and assigned using a similar S/N strategy for vaccinated / unvaccinated cases (**Supplemental Figure 1**). ### Statistical analyses Blood donors were identified to match study participants by age and sex ± 2 years and two donors randomly selected without replacement for each study participant. As not all participants could be matched, criteria were relaxed to include additional donors (**Supplemental Data**). The Rogan-Gladen estimator was used to calculate the true prevalence adjusting for test specificity and sensitivity, with 95% confidence intervals estimated using Blaker’s method.29 For seroprevalence in school staff and blood donors, sensitivities of 95.3% and 96.6%, and specificities of 100% were used for the two S-based assays, respectively.25,30 ## Results ### COVID-19 cases from VCH contact tracing data in District schools (N = 47280 students and N = 7071 school staff) During the 2020-2021 school year 46879 students attended District schools in-person, and 401 students attended an Alternate District School (total of 47280 students). As shown in **Figure 1**, the overall weekly rates of reported COVID-19 cases among staff and students during the pandemic followed a trend similar to the weekly rates among Vancouver residents. The population-level incidence of COVID-19 cases among students (including Vancouver Alternate Secondary Schools) during the 2020/21 school year was 9.8 cases per 1000 students, ranging from 0 to 63 cases per 1000 between schools (**Supplemental Figure 2**). Among schools with at least 1 student case, the median number of student cases was 3, and the median school population was 376 students. In addition, 67 out of the 107 schools (62.6%) had no staff members diagnosed as confirmed, probable, or epidemiologically-linked COVID-19 cases since the beginning of the pandemic. Twenty-six of the 40 schools (65%) with staff cases had only one staff case. Including staff of Vancouver Alternate Secondary Schools, the incidence of reported cases from January 15, 2020 to March 4, 2021 among staff within specific schools ranged from 0 cases per 1000 staff to a maximum of 167 COVID-19 cases per 1000 staff. Among schools with at least 1 staff case, the median number of staff cases was 1, and the median size of each school’s staffing complement was 46.5 staff members. All schools with incidences higher than 80 COVID-19 cases per 1000 staff had only 1 or 2 staff cases among a staffing complement of under 25 staff. The incidence of reported COVID-19 cases from January 15, 2020 to March 4, 2021 was 13 cases per 1000 classroom staff, and 14 cases per 1,000 non-classroom staff (**Supplemental Table 1**). View this table: [Supplemental Table 1:](http://medrxiv.org/content/early/2021/06/18/2021.06.16.21258861/T4) Supplemental Table 1: Reported positive viral testing among entire Vancouver School District staff ### COVID-19 cases self-reported in school staff sample (N = 1689) Staff COVID-19 cases reported to VCH were compared to questionnaire data. In total, there were 2162 access to the screener, of which 1743 staff identified themselves, provided contact information and consented on-line (**Figure 2**). The characteristics of 1689 staff who completed the questionnaire, corresponding to 23.9% of eligible staff (**Table 1**). View this table: [Table 1:](http://medrxiv.org/content/early/2021/06/18/2021.06.16.21258861/T1) Table 1: Baseline characteristics of school staff sample Notably, 63.7% of study participants were elementary school staff and 28.1% were secondary school staff (**Table 1**), which align with District data (not shown). Overall, a majority (78.2%; n = 1320) of school staff were classroom staff, and spent a median of 17.6 hours of contact time with students per week (**Table 1**). The District estimated that 5091 staff have classroom responsibilities. Therefore, we estimate that the study enrolled at least ∼26% of all staff with classroom responsibilities. About one third (37%) of school staff lived with an essential worker, predominantly in the social services, education/research/healthcare, construction, maintenance and skilled trades, and food sectors (**Table 2**). View this table: [Table 2:](http://medrxiv.org/content/early/2021/06/18/2021.06.16.21258861/T2) Table 2: Reported COVID-19 exposures and PCR outcomes among school staff Among the school staff who completed the questionnaire, 51 reported a positive viral test among their household members (**Table 2**). In total, 363 (21.5%) reported a history of close contact with a COVID-19 case at or outside school, but only 24 reported ever testing positive by nucleic acid testing (**Table 2**). Four (16.7%) tested positive by nucleic acid testing prior to the beginning of classes in September 2020. In total, 24 of 1689 school staff self-reported a positive viral test which represents an incidence rate of COVID-19 case of 1.4%. Of the 24 school staff who reported a positive viral test, 5 (21%) reported close contact with a student or co-worker case, including one who required hospitalization during the 2020/21 school year. Seven (29%) reported close contact with a friend or family member with COVID-19, and one reported close contact with both a co-worker and family member with COVID-19. Eleven had unknown sources of acquisition and were not aware of any close contact with a COVID-19 case. ### SARS-CoV-2 seroprevalence in school staff (N = 1556) Of 1689 school staff with prospective questionnaire data, 1556 completed serology testing (median date: March 11, 2021). Serology results for vaccinated and SARS-CoV-2-infected staff are shown in **Supplemental Table 2** and **3**, respectively. In total, 35 tested positive for SARS-CoV-2 by serology. Therefore, the unadjusted prevalence was 2.2% (95%CI: 1.6 – 3.1%), and the seroprevalence after adjusting for the sensitivity and specificity of the test was 2.3% (95%CI: 1.6 to 3.2%). Of the 35 school staff who seroconverted, 29 worked in a classroom setting and one did not work in a classroom setting, but reported more than 20 hours of contact time with students per week, for a seroprevalence also of 2.3% (95%CI: 1.5 – 3.1%). The proportion of staff who tested positive for SARS-CoV-2 by serology between secondary and elementary schools (**Table 3**) corresponded to the proportion of staff in each school level (**Table 1**). In comparison, the unadjusted seroprevalence in age, sex and geography-matched blood donors was 2.0% (95%CI: 1.5 – 2.7%), and 2.3% (95%CI: 1.7 – 3.0%) after adjusting for the sensitivity and specificity of the serology test. View this table: [Supplemental Table 2:](http://medrxiv.org/content/early/2021/06/18/2021.06.16.21258861/T5) Supplemental Table 2: Results of ORTHO (Spike-based) or ROCHE (N-based) serology testing, and according to self-reported viral PCR, for Spike-POSITIVE, VACCINATED cases (n=35) View this table: [Supplemental Table 3:](http://medrxiv.org/content/early/2021/06/18/2021.06.16.21258861/T6) Supplemental Table 3: Results of ORTHO (Spike-based) or ROCHE (N-based) serology testing, and according to self-reported viral PCR, for seropositive, INFECTED cases (n=35) View this table: [Table 3:](http://medrxiv.org/content/early/2021/06/18/2021.06.16.21258861/T3) Table 3: Seropositive cases according to school education level where school staff teaches/assists ## Discussion To the best of our knowledge, this study is one of the largest to report seroprevalence estimates in the school setting in the later phases of the pandemic in the context of in-person schooling and widespread viral transmission. This study found that the seroprevalence among staff in Vancouver public schools was low after a period of widespread community transmission. Results were consistent with both self-reported infection as well as COVID-19 cases reported by VCH. Findings are in keeping with modelling studies 31,32 and data from the UK where low seroprevalence was also measured in teachers, but this was earlier in the pandemic15. Moreover, despite that the seroprevalence in this study represents an approximately three-fold increase relative to previous estimates of 0.55% to 0.6% obtained from Vancouver residents in spring 202033-35, it remained comparable to age/sex and area of residency-matched blood donors. A major advantage of the current study is that it was conducted in BC, one of the few, if not only (as far as we are aware) jurisdictions in North America that maintained in-person schooling during the 2020/21 school year. Study results are drawn from a large sample of staff, including a majority of those exposed to COVID-19 in the classroom. The use of S-based serology assays identified COVID-19 cases up to a year before. The study utilized sensitive serology testing to identify cumulative SARS-CoV-2 cases that may have not come to clinical attention, but could still contribute to the transmission chain36. Conversely, the N-based serology test allowed us to account for vaccinated staff towards the end of recruitment. Among our study participants, 21.5% (363) of school staff reported a close contact with a COVID-19 case, and the majority (76.6%, 278/363) identified contact with a COVID-19 case at school. These data alone could reinforce the perception that schools are a risky environment. However, we could not find evidence to substantiate the perception that a large number of asymptomatic infections have been missed through contact tracing, and thus we were able to provide a more accurate depiction of viral transmission. Despite the high frequency of school staff who reported symptoms (**Table 2**), 90.1% (598/664) had no serological evidence of infection using a conservative testing strategy. Under-ascertainment by viral testing could have been related to the use of targeted testing up until April 2020. However, the relatively high proportion (60%) of cases diagnosed by nucleic acid testing who tested positive via serology suggests good access to viral testing in this specific testing, during the study period. Mitigation strategies employed in BC schools have been shown elsewhere to minimize risk in educators to a level comparable to the risk in the community 37,38. Although non-medical masks were encouraged, but not required in schools until February 2021 (grades 8-12) and end of March 2021 (grades 4-12) (**Appendix**), and are still not required for K-3 students – a situation that is unique in Canada - we also did not detect any meaningful difference in seroprevalence between elementary and secondary school staff. This study has limitations. First, study volunteers are typically healthier, raising a possibility that seroprevalence estimates were underestimated. To estimate this bias, the incidence of COVID-19 cases based on self-report (1.4%) was compared to the contact tracing data in classroom staff across the entire District (1.3%) and suggests that we did not under sampled those who are in direct contact with students. Second, the seroprevalence of school staff was compared to matched blood donors which may underestimate the community prevalence as the blood donors serology were taken in January 2021, prior to sampling of the school cohort, which could only reinforce our conclusions. As others have found, serologic testing in blood donors in general does reflect overall seroprevalence in the community39-42 and we would expect the seroprevalence in the reference group of blood donors for the same period to be higher, which reinforces our study conclusion. Consistent with this, seroprevalence estimates based on anonymized, residual specimens collected by the BC Centre for Disease Control in January 2021 from working age adults (attending one of ∼80 diagnostic service centres in the only outpatient laboratory network in the greater Vancouver area) ranged from 3-4% (DM Skowronski, personal communication). Second, the study had limited power to detect small differences between seroprevalence in school staff and the community. However, it is unlikely that small differences would drastically change the public health recommendations that can be made from the data. Third, exposure risks may differ between school and community settings, which needs to be taken into account when attempting to generalize our findings. In conclusion, this study shows no detectable increase in SARS-CoV-2 infections in school staff working in Vancouver public schools following a period of widespread community transmission (October – May 2021). The combination of population-level COVID-19 data based on nucleic acid testing in symptomatic cases and sensitive serology testing among school staff provide strong evidence that their risk of COVID-19, in the context of mitigation strategies, is not substantially higher than the community. ## Data Availability The data will eventually be made publicly available through the COVID-19 Immunity Task Force ## Authors’ contributions LCM and PML obtained funding as Co-PIs; DMG, AW, MAI, DC, PML and LCM designed the original study concept; SH was involved in the earliest stages of the study, helping with funding applications, study design, ethics applications and data interpretation; MS also advised initial study design; FR helped review the literature; EB constructed and managed the data collection database with support from LCM and AW; LM set-up and coordinated the recruitment of participants; SS and HRR processed all blood samples; VEB supervised the collection of blood samples; AC supervised the analysis of VCH case data among students and school staff; MAI advised statistical study design and analyzed the main seroprevalence estimates; SO provided and analysed matched data from Canadian blood donors; AW performed all other data analyses; CO facilitated communications within the District during the study; DMG & PML drafted the first manuscript with specific sections written by AW, SH, VEB, MAI, AC, CO and LCM. All authors revised the manuscript and approved its final version. ## Conflicts of interest CO is an employee of the Vancouver School District, but the District was not involved in the design, analysis, interpretation of the data, or the drafting of this manuscript; MS has been an investigator on projects funded by GlaxoSmithKline, Merck, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo and VBI Vaccines. All funds have been paid to his institute, and he has not received any personal payments; Authors declare no relevant conflicts of interest. ## SUPPLEMENTAL DATA: Matching scheme of school workers with Canadian blood donors 1537 observations were matched from school workers, with 24 missing postcode, 6 missing sex. In January, seroprevalence data were available from 4910 adults in the lower mainland of British Columbia west of Kamloops and Kelowna. A multiple step procedure aiming for 1:2 matching was employed as shown below. View this table: [Table7](http://medrxiv.org/content/early/2021/06/18/2021.06.16.21258861/T7) ## Acknowledgements We first of all would like to thank the teachers and all other Vancouver School District staff who participated in the study and have been working tirelessly during this pandemic, and the District leadership, particularly Suzanne Hoffman and David Nelson for providing full support during this study; Kathy O’Sullivan for ongoing work reviewing District communications, documents and liaising with school partners throughout the study; Esther Alonso-Prieto for help with the human resource and financial management of this study; Brandon Bates, John Bhullar and Chemistry Laboratory staff at Children’s and Women’s Hospitals and the BC Children’s Hospital Biobank staff for help with sample collection and processing; the District and BC Children’s Hospital communication teams, Kim Schmidt and Lea Separovic for help with advertising; Laura Burns and Janet Simons, from the St-Paul’s Hospital Laboratory, for coordinating the Roche N-based serology testing; Nalin Dhillon from VCH for his analytic expertise; VCH’s Office of the Chief Medical Health Officer, the BC Centre for Disease Control, Dr. Sarka Lisonkova and KS Joseph for ongoing discussions that guided this study, and Steven Drews and Qi-Long Yi for consultation and assistance with matched donor data from Canadian Blood Services. ## APPENDIX 1 COVID-19 mitigations measures in Vancouver schools (2020/21 school year) Prior to reopening, the District implemented COVID-19 safety plans consistent with the British Columbia Centre for Disease Control (BCCDC) COVID-19 Public Health Guidance for K-12 School Settings: [http://www.bccdc.ca/Health-Info-Site/Documents/COVID\_public_guidance/Guidance-k-12-schools.pdf](http://www.bccdc.ca/Health-Info-Site/Documents/COVID_public_guidance/Guidance-k-12-schools.pdf). and Provincial COVID-19 Health & Safety Guidelines for K-12 Settings: [https://www2.gov.bc.ca/assets/gov/education/administration/kindergarten-to-grade-12/safe-caring-orderly/k-12-covid-19-health-safety-guidlines.pdf](https://www2.gov.bc.ca/assets/gov/education/administration/kindergarten-to-grade-12/safe-caring-orderly/k-12-covid-19-health-safety-guidlines.pdf) with support from Public Health. COVID-19 safety plans included public health measures (e.g., protocols for testing and contact tracing), environmental measures (e.g., maximization of distance in classrooms, enhanced cleaning and disinfection, improved fresh air intake), administrative measures (e.g., staggered scheduling, assigning students and staff cohorts), personal measures (e.g., daily symptom checks, physical distancing, hand hygiene, respiratory etiquette), and personal protective equipment. At the beginning of the school year (late August/September), parents were given the option of: 1) full time in-person schooling, 2) home schooling, 3) online learning and 4) a temporary online learning with return to full time schooling with re-entry dates offered later in fall and in January 2021. Daily health assessments were required by all staff and students (via parents) prior to arriving at school and again upon arrival. Anyone with even minor symptoms of cold or flu-like illness was to stay home or go home if these symptoms developed mid-day. Classrooms and other spaces were arranged to maximize distance between students and staff. Class sizes were set by grades: 20 students / class for kindergarten; 22 for grades 1 to 3; 30 for grades 4 to 12. School staff and their students were assigned specific classrooms which were between 75 m – 83 m for elementary students (K to grade 7) and 75 m – 80 m for secondary students (grades 8 to 12) with larger spaces available for elective courses (e.g., physical education, food studies, metal, woodworking, automotive). In addition, secondary classrooms were divided into two separate groupings (AM and PM) of 15 students. The plan also included revising school schedules and learning groups where students also had staggered recess and lunch breaks, and were assigned specific outside areas. Elementary students (K-7) received full day in-class instruction in their assigned learning groups/cohorts. Secondary students (grades 8 to 12) had both in-class instruction and remote learning and their schedules shifted to a quarter system with maximum two in-person classes a day with further instruction given remotely. Ventilation measures included opening windows to promote fresh air flow to classrooms as well as indoor air ventilation improved with the HVAC systems running longer during the day, recirculating less air and the filters changed to higher efficiency (MERV13) filters. Other measures included, the addition of hand sanitizer to classrooms and common areas, directional traffic flow within the school, provision of plexiglass as needed for certain staff roles, and the training of all staff on the safety plan and protocols. In addition to the regular daily cleaning by custodial staff, twice daily disinfection of all high touch frequency items was conducted. Shared items in classrooms were limited and the teachers, or if in secondary school, the students disinfected those used. Initially, masking was encouraged, but not required. Non-medical mask use was encouraged but not required early in the school year, and then in February 2021 masks were required for all staff and students in grades 6-12 in common spaces, and ultimately from April onward for students grades 4-12 at all times while indoors at school. This guidance did not apply if staff or students did not tolerate a mask for health or behavioural reasons. Masks remained recommended for K-3 students. Two reusable cloth masks were distributed to all staff and students in September 2020 and again in January 2021. SARS-CoV-2 nucleic acid amplification (PCR) was available for anyone with symptoms through the provincial health system, and advised for students or staff with fever or new symptoms which persisted for over 24 hours. Tests were generally processed within 24 hours, and positive tests were automatically reported to Public Health which investigated cases within 24 hours, and initiated contact tracing. Symptomatic close contacts were asked to seek testing; asymptomatic testing was not used to release contacts from isolation on an earlier timeline. All close contacts, including close contacts at school, were isolated for at least 14 full days. Entire classes were not isolated unless all members were identified as close contacts. School closures to control transmission were not required during the study period. Also, at the time, vaccination programs had not substantially reached working-age people until April 14, and the majority of school staff vaccinations occurred in May. ## Footnotes * **Funding**: The study was funded by the Government of Canada via its COVID-19 Immunity Task Force (to PML). PML and LCM receive a salary from the British Columbia Children’s Hospital (BCCH) Foundation through the Investigator Grant Award Program. MS is supported via salary awards from the BC Children’s Hospital Foundation, the Canadian Child Health Clinician Scientist Program and the Michael Smith Foundation for Health Research. The BC Children’s Hospital Healthy Starts Theme provided some seed funding at the beginning of the study. * Received June 16, 2021. * Revision received June 16, 2021. * Accepted June 18, 2021. * © 2021, Posted by Cold Spring Harbor Laboratory The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission. ## References 1. 1.Levinson M, Cevik M, Lipsitch M. Reopening Primary Schools during the Pandemic. N Engl J Med. 2020;383(10):981–985. 2. 2.Bullard J, Funk D, Dust K, et al. Infectivity of severe acute respiratory syndrome coronavirus 2 in children compared with adults. CMAJ. 2021;193(17):E601–E606. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiY21haiI7czo1OiJyZXNpZCI7czoxMToiMTkzLzE3L0U2MDEiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMS8wNi8xOC8yMDIxLjA2LjE2LjIxMjU4ODYxLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 3. 3.Macartney K, Quinn HE, Pillsbury AJ, et al. Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study. The Lancet Child & adolescent health. 2020;4(11):807–816. 4. 4.Heavey L, Casey G, Kelly C, Kelly D, McDarby G. No evidence of secondary transmission of COVID-19 from children attending school in Ireland, 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2020;25(21). 5. 5.Yung CF, Kam KQ, Nadua KD, et al. Novel Coronavirus 2019 Transmission Risk in Educational Settings. Clin Infect Dis. 2021;72(6):1055–1058. 6. 6.Kam KQ, Thoon KC, Maiwald M, et al. SARS-CoV-2 viral RNA load dynamics in the nasopharynx of infected children. Epidemiology and infection. 2021;149:e18. 7. 7.Falk A, Benda A, Falk P, Steffen S, Wallace Z, Hoeg TB. COVID-19 Cases and Transmission in 17 K-12 Schools - Wood County, Wisconsin, August 31-November 29, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(4):136–140. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.15585/mmwr.mm7004e3&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=33507890&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F06%2F18%2F2021.06.16.21258861.atom) 8. 8.Brandal LT, Ofitserova TS, Meijerink H, et al. Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2021;26(1). 9. 9.Ismail SA, Saliba V, Lopez Bernal J, Ramsay ME, Ladhani SN. SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England. Lancet Infect Dis. 2021;21(3):344–353. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F06%2F18%2F2021.06.16.21258861.atom) 10. 10.Zimmerman KO, Akinboyo IC, Brookhart MA, et al. Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools. Pediatrics. 2021. 11. 11.Hershow RB, Wu K, Lewis NM, et al. Low SARS-CoV-2 Transmission in Elementary Schools - Salt Lake County, Utah, December 3, 2020-January 31, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(12):442–448. 12. 12.Bark D, Dhillon N, St-Jean M, Kinniburgh B, McKee G, Choi A. SARS-CoV-2 transmission in K-12 schools in the Vancouver Coastal Health Region: a descriptive epidemiologic study. Medrxiv. 2021. doi:[https://doi.org/10.1101/2021.05.15.21257271](https://doi.org/10.1101/2021.05.15.21257271). 13. 13.Varma JK, Thamkittikasem J, Whittemore K, et al. COVID-19 Infections Among Students and Staff in New York City Public Schools. Pediatrics. 2021;147(5). 14. 14.Powell AA, Amin-Chowdhury Z, Mensah A, Ramsay ME, Saliba V, Ladhani SN. Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Primary School Age Children After Partial Reopening of Schools in England. Pediatr Infect Dis J. 2021;40(6):e243–e245. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/inf.0000000000003120&link_type=DOI) 15. 15.Ladhani SN, Baawuah F, Beckmann J, et al. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study. The Lancet Child & adolescent health. 2021. 16. 16.Buonsenso D, De Rose C, Moroni R, Valentini P. SARS-CoV-2 Infections in Italian Schools: Preliminary Findings After 1 Month of School Opening During the Second Wave of the Pandemic. Frontiers in pediatrics. 2020;8:615894. 17. 17.Gras-Le Guen C, Cohen R, Rozenberg J, Launay E, Levy-Bruhl D, Delacourt C. Reopening schools in the context of increasing COVID-19 community transmission: The French experience. Arch Pediatr. 2021;28(3):178–185. 18. 18.Doyle T, Kendrick K, Troelstrup T, et al. COVID-19 in Primary and Secondary School Settings During the First Semester of School Reopening - Florida, August-December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(12):437–441. 19. 19.Haapanen M, Renko M, Artama M, Kuitunen I. The impact of the lockdown and the re-opening of schools and day cares on the epidemiology of SARS-CoV-2 and other respiratory infections in children - A nationwide register study in Finland. EClinicalMedicine. 2021;34:100807. 20. 20.Armann JP, Kirsten C, Galow L, et al. SARS-CoV-2 transmissions in students and teachers: seroprevalence follow-up study in a German secondary school in November and December 2020. BMJ Pediatrics Open. 2021;5:e001036. 21. 21.Szépfalusi Z, Schmidthaler K, Sieber J, et al. Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: A cross-sectional study. Pediatr Allergy Immunol. 2021. 22. 22.Torres JP, Pinera C, De La Maza V, et al. SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study. Clin Infect Dis. 2020. 23. 23.[https://www.covid19immunitytaskforce.ca/wp-content/uploads/2020/07/Core-Elements\_English-New.pdf](https://www.covid19immunitytaskforce.ca/wp-content/uploads/2020/07/Core-Elements_English-New.pdf). accessed May 10, 2021. 24. 24.Garnett E, Jung J, Tam E, et al. Clinical validation and performance evaluation of the automated vitros total Anti-SARS-CoV-2 antibodies assay for screening of serostatus in COVID-19. Am J Clin Pathol. 2020;154(6):742–747. 25. 25.Harritshoj LH, Gybel-Brask M, Afzal S, et al. Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories. J Clin Microbiol. 2021;59(5). 26. 26.Bailey D, Konforte D, Barakauskas VE, et al. Canadian society of clinical chemists (CSCC) interim consensus guidance for testing and reporting of SARS-CoV-2 serology. Clin Biochem. 2020;86:1–7. 27. 27.National S-C-SAEG. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison. Lancet Infect Dis. 2020;20(12):1390–1400. 28. 28.Favresse J, Eucher C, Elsen M, Tre-Hardy M, Dogne JM, Douxfils J. Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies. Clin Chem. 2020;66(8):1104–1106. 29. 29.Reiczigel J, Foldi J, Ozsvari L. Exact confidence limits for prevalence of a disease with an imperfect diagnostic test. Epidemiol Infect. 2010;138(11):1674–1678. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1017/S0950268810000385&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20196903&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F06%2F18%2F2021.06.16.21258861.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000282196000018&link_type=ISI) 30. 30.[https://www.fda.gov/media/144037/download](https://www.fda.gov/media/144037/download). accessed May 17, 2021. 31. 31.Naimark D, Mishra S, Barrett K, et al. Simulation-Based Estimation of SARS-CoV-2 Infections Associated With School Closures and Community-Based Nonpharmaceutical Interventions in Ontario, Canada. JAMA Netw Open. 2021;4(3):e213793. 32. 32.Viner RM, Russell SJ, Croker H, et al. School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review. Lancet Child Adolesc Health. 2020;4(5):397–404. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F06%2F18%2F2021.06.16.21258861.atom) 33. 33.Han MS, Seong MW, Heo EY, et al. Sequential Analysis of Viral Load in a Neonate and Her Mother Infected With Severe Acute Respiratory Syndrome Coronavirus 2. Clin Infect Dis. 2020;71(16):2236–2239. 34. 34.Majdoubi A, Michalski C, O’Connell SE, et al. A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2. JCI insight. 2021;6(8). 35. 35.Saeed S, Drews SJ, Pambrun C, Yi QL, Osmond L, O’Brien SF. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada. Transfusion. 2021;61(3):862–872. 36. 36.Pollock AM, Lancaster J. Asymptomatic transmission of covid-19. BMJ. 2020;371:m4851. [FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYm1qIjtzOjU6InJlc2lkIjtzOjE3OiIzNzEvZGVjMjFfMS9tNDg1MSI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIxLzA2LzE4LzIwMjEuMDYuMTYuMjEyNTg4NjEuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 37. 37.Lessler J, Grabowski MK, Grantz KH, et al. Household COVID-19 risk and in-person schooling. Science. 2021. 38. 38.Dawson P, Worrell MC, Malone S, et al. Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies - St. Louis County and City of Springfield, Missouri, December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(12):449–455. 39. 39.Slot E, Hogema BM, Reusken C, et al. Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands. Nature communications. 2020;11(1):5744. 40. 40.Buss LF, Prete CA, Jr.., Abrahim CMM, et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science. 2021;371(6526):288–292. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjEyOiIzNzEvNjUyNi8yODgiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMS8wNi8xOC8yMDIxLjA2LjE2LjIxMjU4ODYxLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 41. 41.Castro Dopico X, Muschiol S, Christian M, et al. Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden. Journal of internal medicine. 2021. 42. 42.Grant R, Dub T, Andrianou X, et al. SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review. BMJ open. 2021;11(4):e045425. [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYm1qb3BlbiI7czo1OiJyZXNpZCI7czoxMjoiMTEvNC9lMDQ1NDI1IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjEvMDYvMTgvMjAyMS4wNi4xNi4yMTI1ODg2MS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=)